On November 4, 2021 Purple Biotech Ltd. ("Purple Biotech" ", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, reported that management will present a corporate overview at the Jefferies London Healthcare Conference on Wednesday, November 17, 2021 at 12:20 pm GMT (Press release, Purple Biotech, NOV 4, 2021, View Source [SID1234594462]). The conference will take place from November 16 – 19, 2021. Management will be available for one-on-one meetings.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies London Healthcare Conference – November 16-19, 2021
Date: Wednesday, November 17, 2021
Time: 12:20 pm GMT
Webcast: View Source;group=TbkBHEif
Webcast Replay Link: A replay will be accessible on the Events & Presentations page of the Investors section on the Company’s website at View Source